题名

The ＂Treatise on the spleen and stomach＂ (Pí Wèi Lùn) as the first record of multiple sclerosis in the medical literature - A hypothesis based on the analysis of clinical presentation and herbal medicine

DOI

10.1016/j.jtcme.2020.02.009

作者

Andréa D. Fuzimoto；Francesco Brigo

关键词

multiple sclerosis ； autoimmune diseases ； Pí Wèi Lùn ； Bŭ Zhōng Yì Qì Tāng ； Huáng Qí Rén Shēn Tāng

期刊名称

Journal of Traditional and Complementary Medicine

卷期/出版年月

10卷3期（2020 / 05 / 01）

页次

288 - 300

内容语文

英文
中文摘要

Background: The ＂Treatise on the spleen and stomach＂ (Pí Wèi Lùn) is the work of the scholar and physician Li Gao (Jin-Yuan dynasties, 1115-1368 C.E., China). Li Gao described a clinical presentation that today would fall under the diagnosis of Multiple Sclerosis (MS) and proposed the treatment with herbal medicine and nutritional guidelines. The PWL is well known for its application in the treatment of MS and autoimmune conditions. However, this theoretical ＂MS＂ has not yet been analyzed through a scientific investigation, and research on its herbal formulations for MS is scant. Methods: We analyzed the PWL ＂MS＂ clinical presentation considering biomedical diagnostic criteria and neurological correlates. To support our review, we searched Pubmed for studies on the PWL main herbal formulas and their herbs/isolates used for the believed ＂MS＂ which treated experimental autoimmune encephalomyelitis (EAE)/MS. Results: We found a very close correlation between the PWL ＂MS＂ and the current MS diagnosis. Twenty four studies on the herbs-isolates showed significant amelioration of EAE, neuronal damage, and demyelination. Discussion: Collectively, Astragali radix, Ginseng radix, Glycyrrhizae radix, and berberine containing Phellodendri cortex reduced the severity of EAE through different signaling pathways and mechanisms of action. These herbs provided a wide range of properties such as anti-inflammatory, anti-oxidant, anti-microglial activation, anti-infiltration of leukocytes, apoptotic/anti-apoptotic balance, and neuronal protection. Conclusion: Our review proposes that the PWL is the first record of MS in the medical literature. Its formulas and herbs-isolates offer a fertile area for MS research and an invaluable potential for its treatment.
主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. (2018).,Canadian Agency for Drugs and Technologies in Health.
  2. A Look at the disease-modifying therapies for Multiple Sclerosis. Do these new drugs meet an important need? institute for clinical and economic review (ICER). https://icer-review.org/wp-content/uploads/2017/03/CTAF_MS_RAAG_030617.pdf; 2017
  3. Arrieta, M,Bistritz, L,Meddings, J(2006).Alterations in intestinal permeability.Gut,55(10),1512-1520.
  4. Banks, W(2006).The blood-brain barrier as a regulatory interface in the gut-brain axes.Physiol Behav,89(4),472-476.
  5. Beamer, C,Shepherd, D.(2012).Inhibition of TLR ligand- and interferon gammainduced murine microglial activation by Panax notoginseng.J Neuroimmune Pharmacol,7(2),265-276.
  6. Bensky, D,Barolet, R.(1990).Chinese Herbal Medicine, Formulas & Strategies.Eastland Press, Inc..
  7. Bensky, D,Barolet, R.(1990).Chinese Herbal Medicine. Formulas & Strategies.Eastland Press, Inc..
  8. Bensky, D,Clavey, S,Stoger, E.(2004).hinese Herbal Medicine, Materia Medica.Eastland Press, Inc..
  9. Berer, K,Mues, M,Koutrolos, M(2011).Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.Nature,479(7374),538-541.
  10. Bhargava, P,Mowry, E.(2014).Gut microbiome and multiple sclerosis.Curr Neurol Neurosci Rep,14(10),492.
  11. Bing, S,Ha, D,Hwang, I(2016).Protective effects on central nervous system by acidic polysaccharide of Panax ginseng in relapse-remitting experimental autoimmune encephalomyelitis-induced SJL/J mice.Am J Chin Med,44(6),1099-1110.
  12. Bowie, L,Roscoe, W,Lui, E,Smith, R,Karlik, S(2012).Effects of an aqueous extract of North American ginseng on MOG(35-55)-induced EAE in mice.Can J Phys,90(7),933-939.
  13. Brandes, D,Callender, T,Lathi, E,O’Leary, S(2009).A review of disease-modifying therapies for MS: maximizing adherence and minimizing adverse events.Curr Med Res Opin,25(1),77-92.
  14. Browne, P,Chandraratna, D,Angood, C(2014).Atlas of Multiple Sclerosis 2013: a growing global problem with widespread inequity.Neurology,83(11),1022-1024.
  15. Burman, J,Zelano, J(2017).Epilepsy in multiple sclerosis: a nationwide populationbased register study.Neurology,89(24),2462-2468.
  16. Buscarinu, M,Cerasoli, B,Annibali, V(2017).Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study.Mult Scler,23(3),442-446.
  17. Buscarinu, M,Romano, S,Mechelli, R(2018).Intestinal permeability in relapsing-remitting multiple sclerosis.Neurotherapeutics,15(1),68-74.
  18. Butler M, Forte ML, Schwehr N, Carpenter A, Kane R(2015).,未出版
  19. Cai, Z,Wang, C,Yang, W(2016).Role of berberine in Alzheimer’s disease.Neuropsychiatr Treat,12,2509-2520.
  20. Calgano, P,Ruoppolo, G,Grasso, M,De Vicentiis, M,Paolucci, S(2002).Dysphagia in multiple sclerosis - prevalence and prognostic factors.Acta Neurol Scand,105(1),40-43.
  21. Camara-Lemarroy, C,Metz, L,Yong, V(2018).Focus on the gut-brain axis: multiple sclerosis, the intestinal barrier and the microbiome.World J Gastroenterol,24(37),4217-4223.
  22. Chen, F,Wen, Q,Jiang, J(2016).Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?.J Ethnopharmacol,179,253-264.
  23. Chen, L,Gordon, L(2005).Ocular manifestations of multiple sclerosis.Curr Opin Ophthalmol,16(5),315-320.
  24. Chen, X,Liu, Z,Meng, R,Shi, C,Guo, N(2017).Antioxidative and anticancer properties of Licochalcone A from licorice.J Ethnopharmacol,198,331-337.
  25. Chen, Y,Luo, D,Cai, J(2018).Effectiveness and safety of Glycyrrhizae Decoction for Purging Stomach-Fire in Behcet disease patients: study protocol for a randomized controlled and double-blinding trail.Med Baltim,97(13),e0265.
  26. Cheng, Q,Cheng, X,Jiang, G(2009).Multiple sclerosis in China history and future.Mult Scler,15(6),655-660.
  27. Cho, I(2012).Effects of Panax ginseng in neurodegenerative diseases.J Ginseng Res,36(4),342-353.
  28. Compston, A(1988).The 150th anniversary of the first depiction of the lesions of multiple sclerosis.J Neurol Neurosurg Psychiatry,51(10),1249-1252.
  29. Davis, S,Jay, O,Wilson, T(2018).Thermoregulatory dysfunction in multiple sclerosis.Handb Clin Neurol,157,701-714.
  30. Doty, R,Tourbier, I,Pham, D(2016).Taste dysfunction in multiple sclerosis.J Neurol,263(4),677-688.
  31. Ezendam, J,Klerk, A,Gremmer, E,Van Loveren, H(2008).Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents.Clin Exp Immunol,154(3),424-431.
  32. Fasano, A(2011).Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer.Physiol Rev,91(1),151-175.
  33. Fasano, A(2012).Leaky gut and autoimmune diseases.Clin Rev Allergy Immunol,42(1),71-78.
  34. Fasano, A,Shea-Donohue, T(2005).Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases.Nat Clin Pr Gastroenrol Hepatol,2(9),416-422.
  35. Fontes, L,Dos Santos Dias, D,de Carvalho, L(2014).Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis.J Pharm Pharmacol,66(6),886-894.
  36. Freedman, S,Shahi, S,Mangalam, A(2018).The "gut feeling": breaking down the role of gut microbiome in multiple sclerosis.Neurotherapeutics,15(1),109-125.
  37. Gaman, A,Kuo, B(2008).Neuromodulatory processes of the brain-gut axis.Neuromodulation,11(4),249-259.
  38. Gebhardt, M,Kropp, P,Hoffmann, F,Zettl, U(2018).Headache at the time of first symptom manifestation of multiple sclerosis: a prospective, longitudinal study.Eur Neurol,80(3-4),115-120.
  39. Gong, A,Duan, R,Wang, R(2018).Evaluation of the pharmaceutical properties and value of astragali radix.Med Basel,5(2)
  40. Guo, M,Ding, S,Zhao, C(2015).Red Ginseng and Semen Coicis can improve the structure of gut microbiota and relieve the symptoms of ulcerative colitis.J Ethnopharmacol,162,7-13.
  41. Hajar, R(2012).The air of history (Part II) medicine in the middle Ages.Heart Views,13(4),158-162.
  42. Hartung, D,Bourdette, D,Ahmed, S,Whitham, R(2015).The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?.Neurology,84(21),2185-2192.
  43. He, Y,Du, M,Gao, Y(2013).Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels.PloS One,8(10),e76495.
  44. He, Y,Du, M,Shi, H(2014).Astragalosides from Radix Astragali benefits experimental autoimmune encephalomyelitis in C57BL/6 mice at multiple levels.BMC Compl Alternative Med,14,313.
  45. Holmøy, T(2006).A Norse contribution to the history of neurological diseases.Eur Neurol,55(1),57-58.
  46. Hoorbakht, H,Bagherkashi, F(2012).Optic neuritis, its differential diagnosis and management.Open Ophthalmol J,6,65-72.
  47. Hosseinzadeh, H,Nassiri-Asl, M(2015).Pharmacological effects of Glycyrrhiza spp. and its bioactive constituents: update and review.Phytother Res,29(12),1868-1886.
  48. Huang, Q,Wang, M,Chen, X(2016).Can active components of licorice, glycyrrhizin and glycyrrhetinic acid, lick rheumatoid arthritis?.Oncotarget,7(2),1193-1202.
  49. Hwang, I,Ahn, G,Park, E,Ha, D,Song, J,Jee, Y(2011).An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells.Immunol Lett,138(2),169-178.
  50. Ianniti, T,Kerr, B,Taylor, B(2014).Mechanisms and pharmacology of neuropathic pain in multiple sclerosis.Curr Top Behav Neurosci,20,75-97.
  51. Jarius, S,Wildemann, B(2019).The history of neuromyelitis optica. Part 2: "Spinal amaurosis", or how it all began.J Neuroinflammation,16(1),280.
  52. Jeong, H,Kim, J(2002).Induction of inducible nitric oxide synthase expression by 18beta-glycyrrhetinic acid in macrophages.FEBS Lett,513(2-3),208-212.
  53. Jiang, Y,Wu, A,Zhu, C(2013).The protective effect of berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune encephalomyelitis.Neurol Res,35(4),360-368.
  54. Joscelyn, J,Kasper, L(2014).Digesting the emerging role for the gut microbiome in the central nervous system demyelination.Mult Scler,20(12),1553-1559.
  55. Kale, N(2016).Optic neuritis as an early sign of multiple sclerosis.Eye Brain,8,195-202.
  56. Kamisli, S,Ciftci, O,Taslidere, A,Basak Turkmen, N,Ozcan, C(2018).The beneficial effects of 18β-glycyrrhetinic acid on the experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mouse model.Immunopharmacol Immunotoxicol,40(4),344-352.
  57. Kataya, H,Hamza, A,Ramadan, G,Khasawneh, M(2011).Effect of licorice extract on the complications of diabetes nephropathy in rats.Drug Chem Toxicol,34(2),101-108.
  58. Kim, D(2018).Gut microbiota-mediated pharmacokinetics of ginseng saponins.J Ginseng Res,42(3),255-263.
  59. Kim, J,Yi, Y,Kim, M,Cho, J(2017).Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases.J Ginseng Res,41(4),435-443.
  60. Kirby, T,Ochoa-Repáraz, J(2018).The gut microbiome in multiple sclerosis: a potential therapeutic avenue.Med Sci,6(3)
  61. Kotterba, S,Eren, E,Fangerau, T,Malin, J,Sindern, E(2003).Sleepiness and fatigue in multiple sclerosis - comparison of different measuring instruments.Fortschr Neurol Psychiatr,71(11),590-594.
  62. Kumar, DR,Aslinia, F,Yale, SH,Mazza, JJ(2011).Jean-martin Charcot: the father of Neurology.Clin Med Res,9(1),46-49.
  63. Lavasani, S,Dzhambazov, B,Nouri, M(2010).A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells.PloS One,5(2),e9009.
  64. Lee, J,Park, K,Cho, I(2019).Panax ginseng: a candidate herbal medicine for autoimmune disease.J Ginseng Res,43(3),342-348.
  65. Lee, M,Chang, B,Oh, S,Nah, S,Cho, I(2018).Korean Red Ginseng mitigates spinal demyelination in a model of acute multiple sclerosis by downregulating p38 mitogen-activated protein kinase and nuclear factor-κB signaling pathways.J Ginseng Res,42(4),436-446.
  66. Lee, M,Jang, M,Choi, J(2016).Korean red ginseng and ginsenoside-Rb1/-Rg1 alleviate experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.Mol Neurobiol,53(3),1977-2002.
  67. Lee, W,Lin, H,Huang, S(2018).Management of IFN-beta-induced flu-like symptoms with Chinese herbal medicine in a patient with multiple sclerosis: a case report.Compl Ther Med,36,123-128.
  68. Levy, J,Bensmail, D,Brotier-Chomienne, A(2017).Respiratory impairment in multiple sclerosis: a study of respiratory function in wheelchair-bound patients.Eur J Neurol,24(3),497-502.
  69. Li, J,Shi, J,Sun, Y,Zheng, F(2018).Glycyrrhizin, a potential drug for autoimmune encephalomyelitis by inhibiting high-mobility group box 1.DNA Cell Biol,37(21),941-946.
  70. Li, L,Hou, X,Xu, R,Liu, C,Tu, M(2017).Research review on the pharmacological effects of astragaloside IV.Fundam Clin Pharmacol,31(1),17-36.
  71. Liu, D,Zhang, Y,Liu, Y(2018).Berberine modulates gut microbiota and reduces insulin resistance via the TLR4 signaling pathway.Exp Clin Endocrinol Diabetes,126(8),513-520.
  72. Luo, J,Chen, R,Zeng, S(2017).The effects of berberine on a murine model of multiple sclerosis and the SPHK1/S1P signaling pathway.Biochem Biophys Res Commun,490(3),927-932.
  73. Ma, X,Jiang, Y,Wu, A(2010).Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.PloS One,5(10),e13489.
  74. Magna, M,Pisetsky, D(2014).The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases.Mol Med,20,138-146.
  75. Mangalam, A,Shahi, S,Luckey, D(2017).Human gut-derived commensal bacteria suppress central nervous system inflammatory and demyelinating disease.Cell Rep,20(6),1269-1277.
  76. Medaer, R(1979).Does the history of multiple sclerosis go back as far as the 14th century?.Acta Neurol Scand,60,189-192.
  77. Miller, E,Dziedzic, A,Saluk-Bijak, J,Bijak, M(2019).A review of various antioxidant compounds and their potential utility as complementary therapy in multiple sclerosis.Nutrients,11(7),1528.
  78. Mincu, RI,Magda, LS,Florescu, M(2015).Cardiovascular dysfunction in multiple sclerosis.Maedica Buchar,10(4),364-370.
  79. Mohrke, J,Kropp, P,Zettl(2013).Headaches in Multiple Sclerosis Patients Might Imply an Inflammatorial Process.PLoS One,8(8),e69570.
  80. Nayak, S,Matheis, R,Schoenberger, N,Shiflett, S(2003).Use of unconventional therapies by individuals with multiple sclerosis.Clin Rehabil,17(2),181-191.
  81. Neag, M,Mocan, A,Echeverría, J(2018).Berberine: botanical occurrence, traditional uses, extraction methods, and Relevance in cardiovascular, metabolic, hepatic, and renal disorders.Front Pharmacol,9(557)
  82. Nomura, S,Shimakawa, S,Kashiwagi, M,Tanabe, T,Fukui, M,Tamai, H(2015).Acute abdominal pain as the only symptom of a thoracic demyelinating lesion in multiple sclerosis.Brain Dev,37(10),983-987.
  83. Ochoa-Repáraz, J,Kirby, T,Kasper, L(2018).The gut microbiome and multiple sclerosis.Cold Spring Harb Perspect Med,8(6)
  84. Ochoa-Repáraz, J,Mielcarz, D,Wang, Y,Begum-Haque, S,Dasgupta, S,Kasper, L(2010).A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease.Mucosal Immunol,3(5),487-495.
  85. Opara, J,Brola, W,Wylegala, A,Wylegala, E(2016).Uhthoff’s phenomenon 125 years later - what do we know today?.J Med Life,1(9),101-105+1.
  86. Park, K,Tanaka, K,Tanaka, M(2014).Uhthoff’s phenomenon in multiple sclerosis and neuromyelitis optica.Eur Neurol,72(3-4),153-156.
  87. Park, Y,Cho, M,Choi, G,Na, H,Chung, Y(2020).A critical regulation of Th17 cell responses and autoimmune neuro-inflammation by ginsenoside Rg3.Biomolecules,10(1)
  88. Patten, S,Marrie, R,Carta, M(2017).Depression in multiple sclerosis.Int Rev Psychiatr,29(5),463-472.
  89. Pearce, J(2005).Historical descriptions of multiple sclerosis.Eur Neurol,54(1),49-53.
  90. Peterson, C,Rodionov, D,Iablokov, S(2019).Prebiotic potential of culinary spices used to support digestion and bioabsorption.Evid Based Complement Altern Med,2019,8973704.
  91. Peterson, C,Sharma, V,Uchitel, S(2018).Prebiotic potential of herbal medicines used in digestive health and disease.J Alternative Compl Med,24(7),656-665.
  92. Poorjavad, M,Derakhshandeh, F,Etemadifar, M,Soleymani, B,Minagar, A,Maghzi, A(2010).Oropharyngeal dysphagia in multiple sclerosis.Mult Scler,16(3),362-365.
  93. Preziosi, G,Gordon-Dixon, A,Emmanuel, A(2018).Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategies.Degener Neurol Neuromuscul Dis,8,79-90.
  94. Qiao, H,Zhang, L,Shi, H,Song, Y,Bian, C(2018).Astragalus affects fecal microbial composition of young hens as determined by 16S rRNA sequencing.AMB Express,8(1),70.
  95. Qin, X,Guo, B,Wan, B(2010).Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine.J Immunol,185(3),1855-1863.
  96. Racosta, J,Kimpinski, K,Morrow, S,Kremenchutzky, M(2015).Autonomic dysfunction in multiple sclerosis.Auton Neurosci,193,1-6.
  97. Razavi, S,Nazem, G,Mardani, M,Esfandiari, E,Salehi, H,Esfahani, S(2015).Neurotrophic factors and their effects in the treatment of multiple sclerosis.Adv Biomed Res,4(53)
  98. Riccio, P,Rossano, R,Larocca, M(2016).Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: a pilot study.Exp Biol Med,241(6),620-635.
  99. Sand, IK(2018).The role of diet in multiple sclerosis: mechanistic connections and current evidence.Curr Nutr Rep,7(3),150-160.
  100. San-Juan-Rodriguez, A,Good, C,Heyman, R,Parekh, N,Shrank, W,Hernandez, I(2019).Trends in prices, market share, and spending on self-administered disease-modifying therapies for multiple sclerosis in medicare Part D.JAMA Neurol,76(11),1386-1390.
  101. Shahi, S,Freedman, S,Mangalam, A(2017).Gut microbiome in multiple sclerosis: the players involved and the roles they play.Cut Microbes,8(6),607-615.
  102. Shahzad, M,Shabbir, A,Wojcikowski, K,Wohlmuth, H,Gobe, G(2016).The antioxidant effects of radix astragali (Astragalus membranaceus and related species) in protecting tissues from injury and disease.Curr Drug Targets,17(12),1331-1340.
  103. Shin, B,Kwon, S,Park, J(2015).Chemical diversity of ginseng saponins from Panax ginseng.J Ginseng Res,39(4),287-298.
  104. Song, L,Zhou, Q,Wang, H(2017).Chinese herbal medicine adjunct therapy in patients with acute relapse of multiple sclerosis: a systematic review and meta-analysis.Compl Ther Med,31,71-81.
  105. Stuifbergen, A,Harrison, T(2003).Complementary and alternative therapy use in persons with multiple sclerosis.Rehabil Nurs,28(5),141-147+158.
  106. Sun, Y,Chen, H,Dai, J(2018).Glycyrrhizin protects mice against experimental autoimmune encephalomyelitis by inhibiting high-mobility group box 1 (HMGB1) expression and neuronal HMGB1 Release.Front Immunol,9,1518.
  107. Sun, Y,Chen, S,Wei, R(2018).Metabolome and gut microbiota variation with long-term intake of Panax ginseng extracts on rats.Food Funct,6
  108. Sun, Y,Jing, Y,Huang, M(2019).The PD-1/PD-Ls pathway is up-regulated during the suppression of experimental autoimmune encephalomyelitis treated by Astragalus polysaccharides.J Neuroimmunol,332,78-90.
  109. Sun, Y,Lenon, G,Yang, A(2019).Phellodendri cortex: a phytochemical, pharmacological, and pharmacokinetic review.Evid Based Complement Altern Med,2019,7621929.
  110. Sun, Y,Zhang, X,Wang, X,Jia, W(2018).Effect of long-term intake of ginseng extracts on gut microbiota in rats.Zhongguo Zhong Yao Za Zhi,43(19),3927-3932.
  111. Tian, J,Li, X,Zhao, L(2020).Glycyrrhizic acid promotes neural repair by directly driving functional remyelination.Food Funct,11(1),992-1005.
  112. Tracey, JM,Stoffel, JT(2016).Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms.Investig Clin Urol,57(6),377-383.
  113. Unschuld, PU(1985).Medicine in China, A History of Ideas.University of California Press.
  114. Unschuld, PU,Tessenow, H(2011).Huang Di Nei Jing Su Wen. An Annotaded Translation of Huang Di’s Inner Classic - Basic Questions.University of California Press.
  115. Wang, H,Wang, Y(2015).Gut microbiota-brain Axis.Chin Med J Engl,129(19),2373-2380.
  116. Wang, Y,Kasper, L(2014).The role of microbiome in central nervous system disorders.Brain Behav Immun,38,1-12.
  117. Xing, Y,Liu, B,Zhao, Y(2019).Immunomodulatory and neuroprotective mechanisms of Huangqi glycoprotein treatment in experimental autoimmune encephalomyelitis.Folia Neuropathol,57(2),117-128.
  118. Y, Shou-Zhong,L, Jian-Yong,Li, Dong-Yuan’s(1993).Dong-Yuan’s Li. Treatise on the Spleen & Stomach, A Translation of the Pi Wei Lun.Blue Poppy Press.
  119. Yadav, V,Bever, CJ,Bowsen, J(2014).Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology.Neurology,82(12),1083-1092.
  120. Yang, E,Song, I,Song, K(2019).Ethanol extract of Glycyrrhizae Radix modulates the responses of antigen-specific splenocytes in experimental autoimmune encephalomyelitis.Phytomedicine,54,56-65.
  121. Yang, L,Xing, F,Han, X(2019).Astragaloside IV regulates differentiation and induces apoptosis of activated CD4+ T cells in the pathogenesis of experimental autoimmune encephalomyelitis.Toxicol Appl Pharmacol,362,105-115.
  122. Yang, T,Wang, L,Deng, X,Yu, G(2017).Pharmacological treatments for fatigue in patients with multiple sclerosis: a systematic review and meta-analysis.J Neurol Sci,380,256-261.
  123. Zhang, H,Guo, M,Zhang, L(2017).Anti-inflammatory effect and mechanisms of Huangqi glycoprotein in treating experimental autoimmune encephalomyelitis.Folia Neuropathol,55(4),308-316.
  124. Zhou, J,Cai, W,Jin, M(2015).18b-glycyrrhetinic acid suppresses experimental autoimmune encephalomyelitis through inhibition of microglia activation and promotion of remyelination.Sci Rep,5,13713.
  125. Zhu, D,Liu, M,Yang, Y(2014).Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.J Neurosci Res,92(9),1217-1226.
print cancel